Announced Thu, 6 Nov · 22:28 IST

Centenial Surgical Suture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve 1. To approve Standalone ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Centenial Surgical Suture Ltd has informed BSE that its Board of Directors will meet on Thursday, November 13, 2025. The main agenda is to approve the Standalone Un-Audited Financial Results for the quarter and half year ended September 30, 2025, in line with SEBI (LODR) Regulations. The trading window for dealing in the company's securities has been closed since October 1, 2025, and will reopen 48 hours after the results are declared. No other specific business items were mentioned apart from any other business with the chair's permission.

Likely market impact

This is a routine regulatory filing and does not contain any financial data or material business decision. Shareholders should watch for the actual Q2/H1 FY26 results announcement on or after November 13, 2025 for any meaningful impact on the stock.